Literature DB >> 21057260

Aortic stenosis: clinical aspects of diagnosis and management, with 10 illustrative case reports from a 25-year experience.

Christopher E Kurtz1, Catherine M Otto.   

Abstract

Aortic stenosis (AS) is a chronic, progressive disease predominantly affecting individuals aged over 60 years. Symptoms are the result of progressive left ventricular outflow obstruction, and herald rapid clinical decline and high mortality. Medical therapies for AS remain ineffective; operative valve replacement remains the only effective long-term treatment. We review clinical aspects of diagnosis and management of AS in adults, with attention to the natural history before and after valve replacement, assessment of suspected and established AS, and recommended management in general and in difficult clinical scenarios. We conclude with a series of 10 cases illustrating management of common, uncommon, and challenging clinical scenarios encountered at the University of Washington.

Entities:  

Mesh:

Year:  2010        PMID: 21057260     DOI: 10.1097/MD.0b013e3181fe5648

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  16 in total

1.  Realistic Vascular Replicator for TAVR Procedures.

Authors:  Oren M Rotman; Brandon Kovarovic; Chander Sadasivan; Luis Gruberg; Baruch B Lieber; Danny Bluestein
Journal:  Cardiovasc Eng Technol       Date:  2018-04-13       Impact factor: 2.495

2.  Unicuspid unicommissural aortic valve: an extremely rare congenital anomaly.

Authors:  Sukhjeet Singh; Puneet Ghayal; Atish Mathur; Margaret Mysliwiec; Constantinos Lovoulos; Pallavi Solanki; Marc Klapholz; James Maher
Journal:  Tex Heart Inst J       Date:  2015-06-01

Review 3.  Heart Valve Biomechanics and Underlying Mechanobiology.

Authors:  Salma Ayoub; Giovanni Ferrari; Robert C Gorman; Joseph H Gorman; Frederick J Schoen; Michael S Sacks
Journal:  Compr Physiol       Date:  2016-09-15       Impact factor: 9.090

4.  Assessment of risk factors for developing incident aortic stenosis: the Tromsø Study.

Authors:  Gry Wisthus Eveborn; Henrik Schirmer; Per Lunde; Geir Heggelund; John-Bjarne Hansen; Knut Rasmussen
Journal:  Eur J Epidemiol       Date:  2014-07-15       Impact factor: 8.082

Review 5.  Principles of TAVR valve design, modelling, and testing.

Authors:  Oren M Rotman; Matteo Bianchi; Ram P Ghosh; Brandon Kovarovic; Danny Bluestein
Journal:  Expert Rev Med Devices       Date:  2018-10-29       Impact factor: 3.166

6.  Indexes of von Willebrand factor as biomarkers of aortic stenosis severity (from the Biomarkers of Aortic Stenosis Severity [BASS] study).

Authors:  Joseph L Blackshear; Ewa M Wysokinska; Robert E Safford; Colleen S Thomas; Mark E Stark; Brian P Shapiro; Steven Ung; Gretchen S Johns; Dong Chen
Journal:  Am J Cardiol       Date:  2012-11-17       Impact factor: 2.778

7.  Neurotrophin 3 upregulates proliferation and collagen production in human aortic valve interstitial cells: a potential role in aortic valve sclerosis.

Authors:  Qingzhou Yao; Rui Song; Lihua Ao; Joseph C Cleveland; David A Fullerton; Xianzhong Meng
Journal:  Am J Physiol Cell Physiol       Date:  2017-03-29       Impact factor: 4.249

8.  Antioxidant enzymes reduce DNA damage and early activation of valvular interstitial cells in aortic valve sclerosis.

Authors:  Emanuela Branchetti; Rachana Sainger; Paolo Poggio; Juan B Grau; Jeffrey Patterson-Fortin; Joseph E Bavaria; Michael Chorny; Eric Lai; Robert C Gorman; Robert J Levy; Giovanni Ferrari
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-12-13       Impact factor: 8.311

Review 9.  Polymeric trileaflet prosthetic heart valves: evolution and path to clinical reality.

Authors:  Thomas E Claiborne; Marvin J Slepian; Syed Hossainy; Danny Bluestein
Journal:  Expert Rev Med Devices       Date:  2012-11       Impact factor: 3.166

10.  Noggin attenuates the osteogenic activation of human valve interstitial cells in aortic valve sclerosis.

Authors:  Paolo Poggio; Rachana Sainger; Emanuela Branchetti; Juan B Grau; Eric K Lai; Robert C Gorman; Michael S Sacks; Alessandro Parolari; Joseph E Bavaria; Giovanni Ferrari
Journal:  Cardiovasc Res       Date:  2013-03-12       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.